Home › Funds › Rock Springs Capital Management LP › CLDX
Rock Springs Capital Management LP position in CLDX
CELLDEX THERAPEUTICS INC NEW · Health Care
Rock Springs Capital Management LP reported holding 653,344 shares of CLDX (CELLDEX THERAPEUTICS INC NEW) in its Q3 2026 13F filing — a position valued at US$21.2M, representing 1.15% of its reported portfolio and ranking #22 among its reported holdings. Rock Springs Capital Management LP has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR
How Rock Springs Capital Management LP's CLDX position evolved
Rock Springs Capital Management LP first disclosed a stake in CLDX in Q3 2023 at 500,101 shares (US$13.8M). The position peaked in Q1 2024 at 1,372,185 shares, worth US$57.6M. Across 13 filings, Rock Springs Capital Management LP increased the stake 5 time(s), trimmed it 6 time(s) and left it unchanged 1 time(s). The most recent filing (Q3 2026) shows 653,344 shares valued at US$21.2M — a reduction of -45,802 shares quarter over quarter.. Notable position changes include a 94% increase in Q4 2023 (shares rose 6% over the following quarter), a 42% increase in Q1 2024 (shares fell 12% over the following quarter), a 34% trim in Q1 2025 (shares rose 12% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 500.10K | $13.76M | New |
| Q4 2023 | 969.65K | $38.46M | Add |
| Q1 2024 | 1.37M | $57.59M | Add |
| Q2 2024 | 1.40M | $51.78M | Add |
| Q3 2024 | 1.10M | $37.52M | Reduce |
| Q4 2024 | 1.22M | $30.88M | Add |
| Q1 2025 | 812.65K | $14.75M | Reduce |
| Q2 2025 | 812.65K | $16.54M | Hold |
| Q3 2025 | 721.54K | $18.67M | Reduce |
| Q4 2025 | 692.54K | $18.81M | Reduce |
| Q1 2026 | 650.27K | $20.63M | Reduce |
| Q2 2026 | 699.15K | $26.02M | Add |
| Q3 2026 | 653.34K | $21.17M | Reduce |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About CLDX and 13F data
CLDX (CELLDEX THERAPEUTICS INC NEW) is a Health Care company. 40 other funds we track also report a position in CLDX — the largest reported positions include Kynam Capital Management, LP (US$164.2M), Deep Track Capital, LP (US$68.9M), EVENTIDE ASSET MANAGEMENT, LLC (US$61.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding CLDX
- Kynam Capital Management, LP 5.07M sh · $164.19M · Q3 2026
- Deep Track Capital, LP 2.13M sh · $68.89M · Q3 2026
- EVENTIDE ASSET MANAGEMENT, LLC 1.90M sh · $61.46M · Q3 2026
- Commodore Capital LP 1.35M sh · $50.23M · Q2 2026
- Bellevue Group AG 1.20M sh · $44.65M · Q2 2026
- BAKER BROS. ADVISORS LP 1.18M sh · $44.00M · Q2 2026
- Novo Holdings A/S 1.02M sh · $38.14M · Q2 2026
- Eversept Partners, LP 1.17M sh · $38.07M · Q3 2026
- Affinity Asset Advisors, LLC 1.16M sh · $37.61M · Q3 2026
- Elmind Capital, LP 990.00K sh · $36.84M · Q2 2026
- Foresite Capital Management VI LLC 879.71K sh · $32.73M · Q2 2026
- ADAR1 Capital Management, LLC 799.30K sh · $25.91M · Q3 2026
More on Rock Springs Capital Management LP
FAQ
How long has Rock Springs Capital Management LP held CLDX?
Rock Springs Capital Management LP has disclosed CLDX holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Rock Springs Capital Management LP's current position in CLDX?
As of Q3 2026, Rock Springs Capital Management LP holds 653.34K shares of CLDX (CELLDEX THERAPEUTICS INC NEW), valued at $21.17M, representing 1.15% of its reported portfolio and ranking #22.
Has Rock Springs Capital Management LP been buying or selling CLDX?
In the latest 13F filing (Q3 2026), Rock Springs Capital Management LP reduced its position in CLDX. The position peaked in Q1 2024 at 1.37M shares.
Which other funds hold CLDX?
Other major institutional holders of CLDX include Kynam Capital Management, LP, Deep Track Capital, LP, EVENTIDE ASSET MANAGEMENT, LLC, among 40 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.